✦ LIBER ✦

13 EGFR-mutation analysis, treatment and outcomes in newly diagnosed patients with non-small cell lung cancer (NSCLC): a single-institution retrospective review

✍ Scribed by Enting, D.; Januszewski, A.; Benepal, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

18F-FDG uptake and EGFR mutations in pat

✍ Na, Im Il; Byun, Byung Hyun; Kim, Kyeong Min; Cheon, Gi Jeong; Choe, Du Hwan; Ko 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Characteristics, treatment patterns and

✍ Hermes, Andreas; Waschki, Benjamin; Gatzemeier, Ulrich; Reck, Martin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Efficacy of EGFR Tyrosine Kinase Inhibit

✍ Fausto Petrelli; Karen Borgonovo; Mary Cabiddu; Sandro Barni 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 473 KB

KRAS mutations and resistance to EGFR-TK

✍ Mao, Chen; Qiu, Li-Xin; Liao, Ru-Yan; Du, Fang-Bing; Ding, Hong; Yang, Wan-Chun; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 171 KB

P-532 Survival rates in non-selected con

✍ Martens, U.; Bludau, P.; Kaiser, P.; Schulte Mönting, J.; Digel, W. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

PCN37 A Pharmacoeconomic Analysis of the

✍ J. Culig; M. Leppée; N. Skaron-Jakobovic 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB